-Secretase as a Target for Alzheimer's Disease

Author: Wolf, M.S.

Source: Current Topics in Medicinal Chemistry, Volume 2, Number 4, 1 April 2002 , pp. 371-383(13)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

The amyloid- bgr

peptide (A bgr

) is the major protein component of the characteristic cerebral plaques of Alzheimer's disease (AD), and a large body of evidence supports a pathogenic role for this peptide. Thus, the proteases bgr

- and

-secretase that are responsible for carving Ab out of its precursor protein are considered prime targets for therapeutic design. bgr

-Secretase is a membrane-anchored aspartyl protease of the pepsin family, while ggr

-secretase is much more complex. ggr

-Secretase requires presenilin, a multipass membrane protein that is the site of dozens of missense mutations that alter Ab formation and cause hereditary AD. Two conserved aspartates in presenilin are required for ggr

-secretase activity, and aspartyl protease transition-state analogue inhibitors of ggr

-secretase bind directly to presenilins, strong evidence that presenilin is the catalytic component of a novel membrane aspartyl protease. ggr

-Secretase appears to be a multi-component complex of integral membrane proteins, and so far presenilin and a single-pass membrane protein called nicastrin have been identified as members of this complex. A closely similar or identical protease activity is essential for a signaling pathway critical for embryogenesis and hematopoiesis, raising concerns about ggr